PRF Technologies (PRFX) Research & Development (2020 - 2024)

PRF Technologies (PRFX) recorded quarterly Research & Development of -$16.1 million in Q2 2024, down 440.55% on a QoQ basis from $4.7 million in Q1 2024, and down 1396.07% year-over-year from $1.2 million in Q3 2023.

PRF Technologies (PRFX) Research & Development (2020 - 2024) Analysis & Trends

PRF Technologies has disclosed Research & Development across 5 years of filings, most recently posting -$16.1 million for Q2 2024.

  • Quarterly Research & Development fell 1396.07% year-over-year to -$16.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$8.1 million (down 241.64% YoY) and the FY2025 annual result came in at $1.1 million, down 90.29% from the prior year.
  • Research & Development eased to -$16.1 million in Q2 2024, from $4.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $5.2 million in Q4 2021 and troughed at -$16.1 million in Q2 2024.
  • A 5-year average of $125777.8 and a median of $819500.0 in 2022 frame the typical range for Research & Development.
  • Biggest YoY gain for Research & Development was 6631.71% in 2021; the steepest drop was 4387.5% in 2021.
  • Tracing PRFX's Research & Development over 5 years: stood at $446000.0 in 2020, then jumped by 1057.85% to $5.2 million in 2021, then slumped by 62.26% to $1.9 million in 2022, then surged by 40.89% to $2.7 million in 2023, then tumbled by 688.09% to -$16.1 million in 2024.
  • Business Quant data shows PRFX's Research & Development at -$16.1 million in Q2 2024, $4.7 million in Q1 2024, and $2.7 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 PRF Technologies 907,162.18 -2.49 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -16.15 Mn
Mar 31, 2024 4.74 Mn
Dec 31, 2023 2.75 Mn
Sep 30, 2023 589,000.00
Jun 30, 2023 1.25 Mn
Mar 31, 2023 1.45 Mn
Dec 31, 2022 1.95 Mn
Sep 30, 2022 1.05 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 -680,000.00
Dec 31, 2021 5.16 Mn
Sep 30, 2021 -4.04 Mn
Jun 30, 2021 2.76 Mn
Mar 31, 2021 -1.03 Mn
Dec 31, 2020 446,000.00
Sep 30, 2020 -157,000.00
Jun 30, 2020 41,000.00
Mar 31, 2020 24,000.00